Activating Compound | Comment | Organism | Structure |
---|---|---|---|
5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside | - |
Homo sapiens | |
metformin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
phosphoprotein | the enzyme can be activated by direct phosphorylation by the upstream kinase liver kinase B1 at the site of Thr172 on the alpha-subunit, or through indirect allosteric changes of the gamma-subunit, thereby regulating the phosphorylation state of the alpha-subunit | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hepatic stellate cell | - |
Homo sapiens | - |
LX-2 cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
AMP-activated protein kinase | - |
Homo sapiens |
AMPK | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | enzyme phosphorylation inhibits the activation of human hepatic stellate cell line LX-2. Enzyme activation in LX-2 cells inhibits autophagosome formation. Enzyme activation inhibits transforming growth factor-beta-induced intracellular lipid droplet depletion, which relies on increased autophagic flux, and finally inhibits transforming growth factor-beta-induced hepatic stellate cell activation | Homo sapiens |